Novo Nordisk | NVO - Cost Of Sales

Stock Price
47.64
Daily Change
4.32 9.97%
Monthly
-15.74%
Yearly
-44.86%
Q1 Forecast
56.42

Novo Nordisk reported DKK1.95B in Cost of Sales for its fiscal quarter ending in June of 2025.





Cost Of Sales Change Date
ANI Pharmaceuticals USD 116.02M 18.12M Sep/2025
Aurora Cannabis CAD 58.08M 11.99M Sep/2025
Bausch Health Companies USD 750M 14M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Canopy Growth CAD 44.78M 9.32M Sep/2025
Corcept Therapeutics USD 4.6M 1.16M Sep/2025
Drreddys Laboratories INR 40.46B 3.64B Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Merck USD 3.32B 531M Dec/2025
Novartis USD 3.54B 217M Sep/2025
Novo Nordisk DKK 15.15B 2.3B Dec/2025
Novo Nordisk DKK 1.95B 10.94B Jun/2025
Pacira USD 48.6M 6.59M Sep/2025
Perrigo USD 666.2M 27.2M Sep/2025
Prestige Brands USD 131.22M 3.52M Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
Supernus Pharmaceuticals USD 43.29M 5.64M Sep/2025
Zoetis USD 683M 3M Sep/2025